Literature DB >> 2340842

Excessive motor impairment two hours after triazolam in the elderly.

H U Fisch1, G Baktir, G Karlaganis, C Minder, J Bircher.   

Abstract

The pharmacokinetics of triazolam 0.25 mg p.o. and psychomotor coordination were compared in nine healthy, elderly volunteers and nine middle aged controls. Motor coordination, as measured by pursuit rotor performance, was impaired in the elderly even before triazolam administration, and in contrast to the controls it deteriorated to a critical level after the drug. Factors associated with the major decrease in psychomotor performance in the elderly volunteers were poor baseline performance, an additional independent-age factor, and the plasma concentration of free triazolam. Although short acting benzodiazepines may have a less detrimental effect on performance on the morning following their intake, there may be serious motor incoordination and falls may occur if the patients have to rise during the night, particularly when the plasma concentration is high, i.e. about 2 h after dosing.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2340842     DOI: 10.1007/bf00315021

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  12 in total

1.  Benzodiazepine sedatives and the risk of falling in a community-dwelling elderly cohort.

Authors:  G S Sorock; E E Shimkin
Journal:  Arch Intern Med       Date:  1988-11

2.  Risk factors for falls among elderly persons living in the community.

Authors:  M E Tinetti; M Speechley; S F Ginter
Journal:  N Engl J Med       Date:  1988-12-29       Impact factor: 91.245

3.  Assay of triazolam in plasma by capillary gas chromatography.

Authors:  R Jochemsen; D D Breimer
Journal:  J Chromatogr       Date:  1981-05-08

4.  Capillary gas-liquid chromatographic determination of the benzodiazepine triazolam in plasma using a retention gap.

Authors:  G Baktir; J Bircher; H U Fisch; G Karlaganis
Journal:  J Chromatogr       Date:  1985-04-12

5.  Mechanism of the excessive sedative response of cirrhotics to benzodiazepines: model experiments with triazolam.

Authors:  G Bakti; H U Fisch; G Karlaganis; C Minder; J Bircher
Journal:  Hepatology       Date:  1987 Jul-Aug       Impact factor: 17.425

6.  Triazolam concentration-effect relationships in healthy subjects.

Authors:  G Baktir; H U Fisch; P Huguenin; J Bircher
Journal:  Clin Pharmacol Ther       Date:  1983-08       Impact factor: 6.875

7.  Reduced clearance of triazolam in old age: relation to antipyrine oxidizing capacity.

Authors:  D J Greenblatt; M Divoll; D R Abernethy; L J Moschitto; R B Smith; R I Shader
Journal:  Br J Clin Pharmacol       Date:  1983-03       Impact factor: 4.335

8.  Pharmacokinetics of triazolam in geriatric patients.

Authors:  O Dehlin; G Björnson; L Börjesson; L Abrahamsson; R B Smith
Journal:  Eur J Clin Pharmacol       Date:  1983       Impact factor: 2.953

9.  Daytime carryover of triazolam and flurazepam in elderly insomniacs.

Authors:  M A Carskadon; W F Seidel; D J Greenblatt; W C Dement
Journal:  Sleep       Date:  1982       Impact factor: 5.849

10.  Increased sensitivity of the elderly to the central depressant effects of diazepam.

Authors:  N Pomara; B Stanley; R Block; R C Berchou; M Stanley; D J Greenblatt; R E Newton; S Gershon
Journal:  J Clin Psychiatry       Date:  1985-05       Impact factor: 4.384

View more
  3 in total

Review 1.  Abuse and dependence liability of benzodiazepine-type drugs: GABA(A) receptor modulation and beyond.

Authors:  Stephanie C Licata; James K Rowlett
Journal:  Pharmacol Biochem Behav       Date:  2008-01-12       Impact factor: 3.533

Review 2.  The use of microcomputer-based psychomotor tests for the evaluation of benzodiazepine effects on human performance: a review with emphasis on temazepam.

Authors:  G W Kunsman; J E Manno; B R Manno; C M Kunsman; M A Przekop
Journal:  Br J Clin Pharmacol       Date:  1992-10       Impact factor: 4.335

3.  Behavioral vigilance in rats: task validation and effects of age, amphetamine, and benzodiazepine receptor ligands.

Authors:  J McGaughy; M Sarter
Journal:  Psychopharmacology (Berl)       Date:  1995-02       Impact factor: 4.530

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.